78041087 - SIGNALING PROTEOMICS

Information

• Trademark
• 78041087

• Source

• Serial Number

  78041087

• International Classifications

  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  December 29, 2000
  23 years ago

• Transaction Date

  October 24, 2004
  20 years ago

• Status Date

  February 05, 2002
  22 years ago

• Location Date

  November 07, 2002
  22 years ago

• Status Code

  602

• Current Location

  FILE REPOSITORY (FRANCONIA)

  Employee Name

  PERKINS, KARLA M

• Attorney Docket Number

  22686-18

  Attorney Name

  Donna M. Weinstei

  Law Office Assigned Location Code

  L20

• Owners

  • MDS Proteomics Inc.

Case File Statements

• GS0091: Systems and computer programs for assays in the diagnosis of diseases; systems and computer programs for chemical markers for disease states; systems and computer programs for performing diagnostics for diseases; systems and computer programs for determining targets for drugs; systems and computer programs for determining protein and peptide sequences; and scientific instruments, namely, mass spectrometers, automated sample preparers for mass spectrometers, and part and accessories for the foregoing, all for developing assays for the diagnosis of diseases, developing chemical markers for disease states, performing diagnostics for diseases, determining targets for drugs, and determining protein and peptide sequences.
• GS0421: Diagnosing diseases, developing chemical markers for disease states, determining targets for drugs determining protein and peptide sequences, and testing candidate drug compounds for activity; scientific research for others in the fields of the diagnosis of diseases, developing chemical markers for disease states, determining targets for drugs, determining protein and peptide sequences, identifying and/or determining protein-protein, protein-ligand, protein-nucleic acid, protein-small molecule or drug interactions, testing candidate drug compounds for activity, and developing methodologies relating to the foregoing.

Case File Event Statements

• 2/5/2002 - 22 years ago

  3 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2

• 6/6/2001 - 23 years ago

  2 - NON-FINAL ACTION MAILED Type: CNRT

• 5/18/2001 - 23 years ago

  1 - ASSIGNED TO EXAMINER Type: DOCK